GW Researcher Invents ‘Mini Heart’ to Help Return Venous Blood

WASHINGTON (March 27, 2014) — George Washington University (GW) researcher Narine Sarvazyan, Ph.D., has invented a new organ to help return blood flow from veins lacking functional valves. A rhythmically contracting cuff made of cardiac muscle cells surrounds the vein acting as a 'mini heart' to aid blood flow through venous segments. The cuff can be made of a patient’s own adult stem cells, eliminating the chance of implant rejection.

“We are suggesting, for the first time, to use stem cells to create, rather than just repair damaged organs,” said Sarvazyan, professor of pharmacology and physiology at the GW School of Medicine and Health Sciences. “We can make a new heart outside of one’s own heart, and by placing it in the lower extremities, significantly improve venous blood flow.”

The novel approach of creating 'mini hearts' may help to solve a chronic widespread disease. Chronic venous insufficiency is one of the most pervasive diseases, particularly in developed countries. Its incidence can reach 20 to 30 percent in people over 50 years of age. It is also responsible for about 2 percent of health care costs in the United States. Additionally, sluggish venous blood flow is an issue for those with diseases such as diabetes, and for those with paralysis or recovering from surgery.

This potential new treatment option, outlined in a recently published paper in the Journal of Cardiovascular Pharmacology and Therapeutics, represents a leap for the tissue engineering field, advancing from organ repair to organ creation. Sarvazyan, together with members of her team, has demonstrated the feasibility of this novel approach in vitro and is currently working toward testing these devices in vivo.

The study, titled “Thinking Outside the Heart: Use of Engineered Cardiac Tissue for the Treatment of Chronic Deep Venous Insufficiency,” is available at SAGE Journals.

Latest News

Nofar Erlichman, PhD, a postdoctoral associate at the George Washington University School of Medicine and Health Sciences, was awarded a postdoctoral fellowship from the American Cancer Society for her project, “Adipocyte PD-L1 mediates the promotion of mammary tumor growth by the sympathetic…
The GW School of Medicine and Health Sciences welcomed the 2026 cohort of the Integrated Biomedical Sciences (IBS) PhD Program. Over the program’s 30-year history, GW has graduated 340 PhD who have gone on to careers across the biomedical sciences.
The GW Cancer Center announced the appointment of Katherine Chiappinelli, PhD, as Deputy Director for Basic Sciences. In this role, Chiappinelli will work with Edward Seto, PhD, associate center director for basic science at the GW Cancer Center, and the King Fahd Professor of Cancer Biology, to…